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Abstract.  We have examined the properties and intra- 
cellular localization of acetylcholine receptors  in the 
C2 muscle cell line and in a  variant (T-) that accumu- 
lates AChR intracellularly. On immunoblots, the 
subunit structures of the AChR from wild-type and T- 
cells were similar except that the 3' and t5 subunits of 
the variant AChR had altered mobilities. Digestion 
with endoglycosidases H  and F  demonstrated that this 
difference results from a  failure of high-mannose 
N-linked oligosaccharides on AChR subunits to be 
processed to complex forms in the variant. N-linked 
glycosylation of other proteins in the variant was nor- 
mal. When examined by immunocytochemistry, the 
distribution of internal AChR in wild-type cells was 
consistent with a  location both in the endoplasmic 
reticulum and in the Golgi. Variant cells, however, 
showed no evidence of Golgi staining. Subcellular 
fractionation experiments also demonstrated AChR in 
the Golgi fractions of wild-type cells, but not in those 
derived from T- cells. We conclude that in T- myo- 
tubes most of the AChR fails to be transported out of 
the endoplasmic reticulum. 
M 
EMBRANE proteins follow a  common path of as- 
sembly and transport to the cell surface (reviewed 
in Burgess and Kelly,  1987; Pfeffer and Rothman, 
1987). They are synthesized, glycosylated and assembled in 
the ER, transported to the Golgi apparatus where N-linked 
oligosaccharides  are  processed  and  other  modifications 
made, and then transported to the cell surface. Proteins may 
deviate from this pathway under a variety of circumstances. 
Misfolding of the protein or failure to assemble can result in 
retention in the ER (Doyle et al.,  1985, 1986;  Copeland et 
al.,  1986, 1988;  Gething et al.,  1986;  Kreis and Lodish, 
1986; Salter and Cresswell, 1986; Doms et al., 1988; Chen 
et al., 1988). Experimental manipulations such as change in 
pH, reduced temperature, or the addition of ionophores can 
also disrupt the movement of proteins to the surface, result- 
ing  in  their  intracellular  retention  (Matlin  et  al.,  1988; 
Strous et al., 1985; Matlin, 1986; Griffiths et al., 1983; Mat- 
lin and Simons, 1983; Saraste and Kuismanen, 1984). These 
deviations from the normal pathway are useful for its dissec- 
tion and for attempts to understand its regulation. 
The nicotinic acetylcholine receptor (AChR)' is an oligo- 
meric membrane protein expressed in differentiated muscle 
cells that follows a pathway to the cell surface resembling that 
of other membrane proteins (Anderson and Blobel,  1981, 
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1983;  Merlie et al.,  1983;  Carlin and Merlie,  1987).  The 
receptor is assembled in the ER from four highly homolo- 
gous  glycosylated subunits  to  form  the  structure  c~2fl3,6 
(Smith et al.,  1987).  It is then transported to the Golgi ap- 
paratus (Fambrough and Devreotes,  1978),  where some of 
the oligosaccharides on the 3' and 6 subunits are processed 
to complex forms (Gu and Hall, 1988b),  and the fully pro- 
cessed AChR is then transported to the cell surface (Dev- 
reotes et al.,  1977; Merlie et al.,  1983). 
We have recently investigated a genetic variant of the C2 
mouse  muscle  cell  line,  T-,  that  expresses  a  reduced 
amount of AChR on its  surface (Black and Hall,  1985). 
Previous experiments (Gu et al., 1989) have shown that, al- 
though the T- variant synthesizes a normal amount of re- 
ceptor, only a small fraction of the assembled AChR reaches 
the cell surface. The remainder is accumulated in the cell in- 
terior. Here we investigate the molecular properties and in- 
tracellular location of the AChR in wild-type and variant C2 
myotubes to determine the point in the intracellular pathway 
to the surface at which the AChR in variant cells has been 
retained or diverted. 
Materials and Methods 
Antibodies 
mAbs 61 and 124 (Tzartos et al., 1981; Gullick and Lindstrom, 1983), which 
recognize the o~ and/3 subunit, respectively, were generously given to us 
by Dr. Jon Lindstrom (The Salk Institute for Biological Studies, San Diego, 
CA); mAb 14-3-F7,  specific for the a  subunit, was prepared as described 
in Dowding and Hall (1987);  anti-~ 485 and anti-~5 486 antibodies, which 
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prepared as described in Gu and Hall (1988a); anti-BiP (immunoglobulin 
heavy chain-binding protein) monoclonal antibody (Bole et al.,  1986) was 
the generous gift of Dr.  David Bole (Yale University, New Haven, CT); 
anti-Golgi  monoclonal  antibody  (Allan  and  Kreis,  1986)  was  kindly 
provided by Dr. V. Allan (University of California, San Francisco, CA); and 
a polyclonal antiserum raised against the Japanese strain of influenza virus 
was the generous girl of Dr. Judith White (University of California, San 
Francisco, CA). 
Cell Culture and Metabolic Labeling Conditions 
The  C2  mouse  muscle cell  line,  isolated originally by  Yaffe and  Saxel 
(1977), was maintained in DME H-16 supplemented with 20% FBS and 0.5 % 
chick embryo extract as described in Inestrosa et al. (1983)  and Gu et al. 
(1985).  Differentiation of myoblasts into myotubes was stimulated by trans- 
ferring cells into fusion medium (DME H-16 supplemented with 10% horse 
serum). Cells were usually used 3-4 d after transfer to fusion medium. 
Metabolic labeling of C2 myotubes in culture was routinely carried out 
with  [35S]methionine/cysteine  (Tran  35S  label;  ICN  Radiochemicals,  Ir- 
vine, CA).  To label AChRs, myotube cultures in  10-cm dishes were in- 
cubated  with  1  mCi  [35S]methionine/cysteine  overnight  in  methionine/ 
cysteine-free DME  H-16  supplemented with 2%  horse serum.  To  label 
fibronectin, cells were incubated with labeled amino acids for 6 b under the 
same conditions. To pulse-label hemagglutinin produced by cells infected 
with influenza virus, infected cells in 60-ram dishes were washed with 2 
ml methionine/cysteine-free  medium and incubated for 15 rain. They were 
labeled with the same medium containing 0.5 mCi [35S]methionine/cysteine 
for 10 min at 37°C.  Incorporation of radioactive amino acids was stopped 
by washing the cells with 5 ml PBS containing 2 mg/ml unlabeled methio- 
nine and cysteine; the cells were then chased in 5 ml fusion medium for the 
indicated time. 
AChR Preparation and Western Blot Analysis 
AChRs were isolated from C2 myotube cultures according to the procedure 
previously described (Gu and Hall,  1988b).  Myotubes were collected by 
scraping into PBS with a rubber policeman. The cell pellet obtained by cen- 
trifugation was then extracted with a buffer containing 50 mM Tris-HC1  (pH 
7.4), 50 mM NaC1,  1% Triton X-100, 2 mM EDTA, 2 mM EGTA, 0.4 mM 
PMSE  1 mM N-ethylmaleimide (NEM),  1 mM sodium tetrathionate, 20 
#g/ml leupeptin, 20 #g/ml pepstatin, 20 U/ml aprotinin (buffer A). For iso- 
lation of AChRs from metabolically labeled cultures, the extract was applied 
to an t~-cobratoxin-Sepharose column and the bound receptor eluted with 
1 M carbamylcholine. Receptor was further purifed by immunoprecipita- 
tion with mAb 61, a monoclonal antibody that recognizes the a  subunit of 
the receptor (Tzartos et al., 1981). For endoglycosidase digestion and Western 
blot analysis, AChRs in extracts of unlabeled cells were adsorbed to a-bung- 
arotoxin (u-BuTx)  coupled to Sepharose and eluted by boiling in 0.6% SDS; 
they were then treated with endoglycosidase H (endo H) or endoglycosidase 
F  (endo F). AChRs were routinely analyzed on 9%  SDS polyacrylamide 
gels and, for Western blot analysis, transferred to nitrocellulose membranes 
and probed with subunit-specific antibodies as described in Gu and Hall 
(1988b).  In some experiments, receptors on the cell surface were separated 
from internal ones by incubating intact myotubes with unlabeled ot-BuTx, 
followed by extraction and  immunoprecipitation with anti-a-BuTx  anti- 
bodies. 
Isolation of Fibronectin 
Fibronectin was isolated from myotube culture medium according to the 
method of Ruoslahti et al. (1982),  using affinity chromatography on gelatin- 
Sepharose  (Pharmacia  Fine  Chemicals,  Piscataway,  NJ)  as  the  single 
purification step. 
Expression and Isolation of Influenza Hemagglutinin 
C2  myotubes were  infected with the Japanese  strain  of influenza virus 
(generously given to us by Dr. Judith White, University of California, San 
Francisco,  CA) according to the procedure described by  Yewdell et al. 
(1988).  Confluent myotube cultures in 60-ram dishes were rinsed with 5 ml 
PBS and incubated at room temperature with 2 ml DME H-16 supplemented 
with 0.1% BSA and 20 mM Hepes (pH 7.6) containing 400 hemagglutinin 
(HA) units of infectious influenza virus. 5 ml of DME supplemented with 
10% horse serum were then added and the incubation continued for 6 h at 
37°C.  Cells were then washed with PBS and  labeled with  [35S]methio- 
nine/cysteine as described above. Pulse-chase labeled cells were collected 
by scraping them into PBS and the cell pellet obtained by centrifugation ex- 
tracted in 50 mM Tris-HCI (pH 7.4),  1% Triton X-100, 2 mM EDTA, 2 mM 
EGTA, 1 mM PMSE 20 U/ml aprotinin, 20 #g/ml soybean trypsin inhibi- 
tor. HA was isolated from the extract by immunoprecipitation with an an- 
tiserum raised against the influenza virus. Immunoprecipitates were washed 
with 1 M NaCl, 0.1% SDS, 0.1% Triton X-100, 50 mM Tris, pH 7.4 and 
eluted by boiling in 0.6%  SDS. 
Endo H and Endo F Digestion 
Endoglycosidase digestion of isolated proteins was carried out as previously 
described (Gu and Hall,  1988b).  For digestion of the AChR, the digestion 
mixture contained 0.2%  SDS, 20 mM sodium citrate (pH 5.5),  10 mM 
EDTA, and 10 mU/ml endo H (Boehringer Mannheim Biochemicals, Indi- 
anapolis, IN) or 4 U/ml endo F (New England Nuclear, Boston, MA); for 
digestion of fibronectin and HA, the reaction mixture also contained 0.1 M 
~-mercaptoethanol. The reaction was carried out at 37°C for 15-18 h and 
was stopped by boiling in SDS-PAGE sample buffer. 
Subcellular Fractionation of C2 Myotubes 
Subcellular fractionation of C2 myotubes were carried out as described by 
Smith et al. (1987)  for BC3H-I cells. Wild-type or T- myotube cultures in 
10-cm dishes were rinsed twice with TBS (25 mM Tris-HCI, pH 7.4,  144 
mM NaCI) and collected in 0.7 ml homogenization buffer containing 2.7 % 
sucrose,  1 mM  MgCl2,  5  mM  K-Hepes, pH  7.5. The  cells were then 
homogenized with seven strokes in a 7-ml Dounce homogenizer (Wheaton 
Instruments Div., Millville, N J). The homogenate was loaded on a 20-69% 
sucrose gradient and centrifuged in a rotor (Model SW 60; Beckman Instru- 
ments Inc., Palo Alto, CA) for 30 min at 60000 rpm as described in Smith 
et al. (1987).  200 p,l fractions were then collected from the top of the gra- 
dient with a micropipct and each fraction assayed for AChR and for ER and 
Golgi markers. 
Assays 
The amount of AChR in sucrose gradient fractions was determined with the 
DEAE filtration assay described in Brockes and Hall (1975).  Aliquots of 
gradient samples were mixed with equal volumes of 2× concentrated buffer 
A  and incubated with  t25I-labeled  a-BuTx (Amersham Corp.,  Arlington 
Heights, IL)  for 2  h at 37°C.  The reaction mixture was then applied to 
DEAE  filters  and bound receptor determined by counting in  a  gamma 
counter. Glucose-6-pbosphatase, UDP-galactose/N-acetylglucosamine ga- 
lactosyltransferase, and rnannosidase II activities were measured according 
to the methods described in Smith et al.  (1987). 
lmmunocytochemistry 
For immunofluorescence, C2 cells were grown on round glass coverslips 
(gold seal,  1/4" diam) that were kept in 24-well plates. All solutions were 
prepared with PBS unless otherwise stated. 
For staining of the intracellular AChR, the cells were incubated with 1 
#M unlabeled t~-BuTx for 90 min to block surface AChR. They were then 
rinsed with PBS, fixed with 2% paraformaldehyde for 20 rain, permeabi- 
lized with 1% Triton X-100 for l0 rain, and stained for 2 h with rhodamine- 
conjugated  a-bungarotoxin  (rho-~-BuTx)  in  PBS  containing  1%  BSA 
(PBS/BSA). They were rinsed again and mounted in glycerol supplemented 
with para-phenylenediamine (Platt and Michael,  1983). 
For staining of the Golgi apparatus, cells were fixed as described above 
and permeabilized with 0.1% Triton X-100/0.5%  SDS in PBS. They were 
incubated for 15 min in 10% FCS/4% BSA to block nonspecific binding and 
then for 2 h with an anti-Golgi monoclonal antibody diluted in the same 
buffer. This antibody recognizes a 110-kD Golgi protein and shows a pattern 
of staining that is very similar to that obtained with classical Golgi markers 
(Allan and Kreis, 1986). Finally, the cells were incubated with a fluorescein- 
conjugated goat anti-mouse antibody (Cappel Laboratories, Malveru, PA) 
in PBS/BSA, rinsed and mounted as described above. 
For staining of the ER, cells were handled as described in the previous 
section, except that permeabilization was with  1%  Triton X-100  and the 
blocking step was omitted. An anti-immunoglobulin heavy chain-binding 
protein (BiP) rat monoclonal antibody (Bole et al.,  1986) was applied for 
2  h  in  PBS/BSA,  followed by fluorescein-conjugated goat anti-rat anti- 
bodies. 
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of AChRs in wild-type and T- 
variant cells.  Wild-type  (Wt) 
or T- myotube cultures  were 
metabolically  labeled  over- 
night  with  [35S]methionine/ 
cysteine. The cells were then 
collected  and  extracted  and 
AChRs  isolated  from the  ex- 
tract by affinity  chromatogra- 
phy on an a-cobratoxin-Seph- 
arose  column,  followed  by 
immunoprecipitation  with mAb 
61  as  described  in  Materials 
and Methods.  Immunoprecipi- 
tams were analyzed on 9% SDS 
polyacrylamide gels under re- 
ducing conditions and fluoro- 
graphed. The figure shows an 
autoradiograph  of the gel.  Note 
that the mobilities of the bands 
tentatively identified  as the 3' 
and t5 subunits of the receptor 
are different in wild-type and 
T- cells. 
were used: endo H, which recognizes N-linked oligosaccha- 
rides  with  five  or  more  mannose  residues  (high-mannose 
oligosaccharides) (Tarentino et al.,  1978), and endo F, which 
cleaves  all  types  of  N-linked  oligosaccharides,  including 
both high-mannose and complex type oligosaccharides (Elder 
and  Alexander,  1982). 
The results of the immunoblotting  experiment confirmed 
and  extended  those  of the  metabolic  labeling  experiment. 
Results 
T- AChR  Has Abnormal  N-linked Oligosaccharides 
To compare the subunit structures of the AChR in wild-type 
and  T-  myotubes,  we  labeled  myotube  cultures  overnight 
with  [35S]methionine/cysteine  and  purified  the  AChR  by 
affinity  chromatography  on  cobratoxin-Sepharose  column, 
followed by immunoprecipitation with mAb 61, a monoclonal 
antibody that recognizes the t~ subunit (Tzartos et al.,  1981). 
The purified AChRs were then analyzed by SDS-PAGE and 
fluorography.  Four bands were detected  in each preparation 
(Fig.  1).  All  appeared  to be subunits  of the  AChR  as they 
were not present in a control preparation in which the myo- 
tube extracts were incubated  with a-BuTx before the cobra- 
toxin-Sepharose purification step (data not shown).  The two 
bands of lower apparent molecular weights corresponded to 
the  previously  identified  t~ and/3  subunits  of the  receptor, 
respectively (Black et al.,  1987),  and had  identical  mobili- 
ties  for wild-type  and  T- myotubes.  The other  two  bands, 
which  were  tentatively  identified  as  the  3,  and  ~  subunits, 
both  showed  slightly  increased  mobilities  in  the  T-  AChR 
relative to the wild-type AChR (Fig.  1),  suggesting that the 
and ~ subunits in T- cells are different from those in wild- 
type cells.  As two of the subunits have altered mobilities,  a 
difference  in covalent modification of the subunits,  such  as 
glycosylation,  is  more  likely  than  a  difference  in  peptide 
backbone. 
To identify the AChR subunits unequivocally and to char- 
acterize further the difference between the two AChR prepa- 
rations,  AChRs  from  wild-type  or  T-  myotubes  were  par- 
tially  purified  by  affinity  chromatography  on  an  a-BuTx- 
Sepharose  column,  subjected  to SDS-PAGE,  and  analyzed 
by immunoblotting using antibodies  specific for each of the 
four subunits of the muscle AChR (Gu and Hall,  1988a,b). 
Samples  of the  AChRs  from  wild-type  and  T-  myotubes 
were treated with glycosidases before immunoblotting to test 
for  changes  in  N-linked  glycosylation.  Two  glycosidases 
Figure 2.  N-linked glycosylation of AChR in wild-type and T- C2 
myotuhes. AChRs partially purified from wild-type control (lanes 
C,  lanes  1,  3,  and 5)  or T- variant (lanes  V,  lanes 2,  4,  and  6) 
myotubes by affnity chromatography on t~-BuTx-Sepharose  column 
were either mock digested (lanes 1 and 2), digested with endo H 
(lanes 3 and 4), or endo F (lanes 5 and 6) for 16 h at 37°C  under 
conditions described  in  Materials  and  Methods.  They were then 
subjected  to  reducing  SDS-PAGE  and  immunoblotting  analysis. 
Antibodies  used  as  probes  were  (a)  mAb  14-3-F-7  to  detect  c~ 
subunit, (b) mAb 124 to detect/3 subunit, (c) anti-3" 485 antibodies 
to detect 3, subunit or (d) anti-6 486 antibodies to detect 6 subunit. 
The figure shows  autoradiographs of the blots.  Note that the size 
of 3, and 6 subunits are different in AChRs of wild-type and of T 
cells (c and d, compare lanes 1 and 2) and that endo H digestion 
has different effects on their mobilities (c and d, compare lanes 3 
and  4).  Numbers  on  the  left  correspond  to  molecular  mass  in 
kilodaltons. 
Gu et al. AChR Retention in ER of Muscle Cell Variant  731 Figure 3. N-linked glycosylation of fibronectin in wild-type and T- 
cells. Wild-type (WT) or T- myotube cultures were incubated with 
[35S]methionine and cysteine for 6 h. Fibronectin secreted into the 
medium by the cells was then isolated by affinity chromatography 
on gelatin-Sepharose  column,  mock digested (lanes 1), digested 
with endo H (lanes 2), or endo F (lanes 3), and subjected to SDS- 
PAGE on a 5-10% gradient gel, followed  by fluorogmphy.  The figure 
shows an autoradiograph that had been exposed for 12 h. Molecular 
mass standards on the right are laminin heavy chain (250 kD), lami- 
nin light chain (200 kD), and/3-galactosidase (116 kD).  WT, wild- 
type cells;  T-, T- variant cells; FN, fibronectin. 
The mobilities of the single a  band, identified with mAb 14- 
3-F7 (Dowding and Hall, 1987), were identical in wild-type 
and T- AChR preparations (Fig. 2 a, lanes 1 and 2).  Treat- 
ment with endo H increased the mobilities of the c~ subunits 
equally in both preparations (Fig. 2 a, lanes 3 and 4). Treat- 
ment  with  endo  F  also  increased  the  mobilities  of the  c~ 
subunits,  and to the  same extent as did endo H  (Fig.  2 a, 
lanes 5  and 6).  Thus,  no difference was detected between 
wild-type  and  T-  a  subunit  either  with  or  without  en- 
doglycosidase treatment. We conclude that the a  subunit of 
the C2 AChR, like that of the rat muscle and Torpedo AChRs 
(Gu and Hall,  1988b;  Nomoto et al.  1986),  contains only 
high-mannose oligosaccharides and that the c~ subunits are 
indistinguishable  in  the  AChRs  of wild-type and  T- myo- 
tubes. 
Similar results were obtained for the/~ subunit (Fig. 2 b). 
The  /3  subunit,  detected  by  mAb  124  (Gullick and  Lind- 
strom,  1983),  appears  to  contain  only  endo  H-sensitive, 
high-mannose  N-linked  oligosaccharide  residues,  and  no 
difference was found between wild-type and T- AChR.  In 
the case of the ~ subunit, the product of endo F digestion had 
a slightly higher apparent molecular weight than the product 
of endo H digestion (Fig.  2 b, compare lanes 3 and 4  with 
lanes 5 and 6), as was seen with the ~ subunit of rat muscle 
AChR (Gu and Hall,  1988b)  and with influenza virus HA 
protein (see Fig.  4).  The reason for this is unknown. 
Different results were obtained for the 3' and 6 subunits. 
First,  two bands were observed for each subunit (Fig. 2,  c 
and d). This pattern is similar to that seen on Western blots 
of the 3' and ~5 subunits  of rat muscle AChR under similar 
conditions, and is apparently due to proteolysis (Gu and Hall, 
1988b).  Second, as was found in the metabolic labeling ex- 
periment, the mobilities of both 3' and ~5 subunits were in- 
creased in the T- AChR compared to that of wild-type AChR 
(Fig.  2,  c and d,  lanes 1 and 2  in both).  In each case, this 
difference was abolished by endo F treatment (Fig. 2, c and 
d,  lanes 5  and 6  in both).  Thus the difference in the elec- 
trophoretic mobilities of the 3' and ~5 subunits  in wild-type 
and T- AChRs arises from a difference in N-linked glycosy- 
lation. 
Further, a comparison of the products of endo H and endo 
F digestions shows that in the AChRs of wild-type cells, both 
3' and ~5 subunits have a mixture of endo H-sensitive (high- 
mannose) and endo H-resistant (complex) oligosaccharides. 
The 3' and ~5 subunits from the T- AChRs, in contrast, have 
only endo H-sensitive, high-mannose oligosaccharides. In the 
wild-type AChR,  endo H  treatment produced a  small shift 
in the mobility of the 3' subunit,  and endo F  treatment pro- 
duced a larger shift (Fig. 2 c, lanes 1, 3, and 5), whereas in 
the case of the T- AChR,  both endo H  and endo F  treat- 
ment produced the same shift in the 3" subunit mobility (Fig. 
2 c, lanes 2, 4, and 6). Similar results were obtained for the 
~5 subunit. Thus, the oligosaccharides in the 3' and 5 subunits 
in the T- variant are defective in that they are not processed 
to complex, endo H-resistant forms as they are in wild-type 
cells. 
Other Proteins in the 7"- Variant Are Normally 
Glycosylated 
The failure of T- myotubes to process high-mannose oligo- 
saccharides on the 3, and 6 chains of the AChR to complex 
forms could either be a general defect that affects all glyco- 
proteins or one that is specific to the AChR. Two experimen- 
tal approaches were taken to distinguish these possibilities. 
First, we compared the pattern of sensitivity of wild-type and 
T- variant cells to various lectins,  a  technique  commonly 
used to detect defects in glycosylation of surface proteins in 
other types of variant cell lines (Stanley,  1984;  Kingsley et 
al., 1986). No significant differences were seen in the pattern 
of susceptibility of the two cell types to wheat germ aggluti- 
nin, ricin, and concanavalin A (data not shown), suggesting 
that T- cells do not have a general defect in glycosylation of 
surface proteins. 
Next  we  examined  the  N-linked  glycosylation  of  two 
specific proteins,  fibronectin,  an  endogenous  extracellular 
matrix protein that is secreted into the medium of myocytes, 
and influenza virus HA protein, a foreign membrane protein 
that is expressed on the surface of cells infected with influ- 
enza virus. Fibronectin was isolated from the media of wild- 
type  or  T-  myotube  cultures  that  had  been  labeled  with 
pS]methionine and cysteine for 6  h.  In preparations from 
both wild-type and T- cultures,  endo H  produced little or 
no shift in the electrophoretic mobility of fibronectin (Fig. 3, 
lanes 2),  while endo F  treatment produced a  distinct  shift 
(Fig. 3, lanes 3). No difference was observed under any con- 
dition  in  the  mobilities of fibronectin in  wild-type and T- 
cells. 
The  fibronectin  preparation  obtained  from  T-  cultures 
also contained a protein of 135,000  Mr that was not detect- 
able in wild-type cultures (Fig. 3). Although we do not know 
the  identity  of this  protein,  its  behavior after glycosidase 
treatment  clearly  indicated  that  it  also  contained  endo 
H-resistant oligosaccharides. 
Similar results were also obtained with influenza HA pro- 
tein expressed in wild type and T- cultures after infection 
with influenza virus.  In both cases,  HA proteins remained 
endo H-sensitive shortly after synthesis (Fig. 4 A), but be- 
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T- ceils.  Wild-type  (lanes  1-3)  or T- (lanes 4-6)  myotube cul- 
tures  were  infected with  influenza virus  and  pulse  labeled  with 
[35S]methionine/cysteine for 10 min as described  in Materials and 
Methods. Cell extracts were then prepared either immediately after 
the pulse (A) or after a 60-min chase in the presence of excess unla- 
beled amino acids (B) and immunoprecipitated with an antiserum 
raised  against  the  virus.  Immunoprecipitates  were  either  mock- 
digested (lanes 1 and 4), digested with endo H (lanes 2 and 5), or 
endo  F  (lanes  3  and  6),  analyzed  on 9%  SDS  polyacrylamide 
gels under reducing conditions, and fluorographed. Control experi- 
ments showed that all the HA protein was intracellular  at the end 
of the pulse and that ~50% reached the cell surface during the 60- 
min chase  in both cell types. 
came  endo  H-resistant after  a  60-min  chase  (Fig.  4  B). 
These results, taken together with those on fibronectin, indi- 
cate that T- cells are capable of producing complex N-linked 
sugars, and that the alteration in oligosaccharides on the 3" 
and 5 chains of the AChR is not a  general defect. 
Surface AChRs in T- Cells Contain Normal 
N-linked Sugars 
Are the oligosaccharides on the surface AChRs of T- cells 
sensitive to endo H? Surface AChRs were isolated from wild- 
type  and  T-  myotubes  by  labeling  intact  myotubes  with 
a-BuTx,  followed  by  extraction  and  immunoprecipitation 
with  anti-ot-BuTx antibodies.  Immunoblots of the  AChRs 
were then made using anti-3' 485 antibodies (Gu and Hall, 
1988a,b) as the probe. The results (Fig. 5) show that the 3' 
subunit  of surface AChRs derived from T- myotubes, like 
those from wild-type myotubes, contain a  mixture of endo 
H-sensitive and endo H-resistant forms of N-linked sugars. 
Thus the surface AChRs  in T- cells have normal N-linked 
sugars. 
Immunofluorescent Localization of Internal AChR 
The localization of the internal AChR in wild-type and T- 
myotubes  was  investigated  by  immunofluorescence.  Myo- 
tube cultures were incubated with unlabeled ct-BuTx to block 
surface AChRs, then fixed, permeabilized, and stained with 
rho-ot-BuTx as described in Materials and Methods. In paral- 
lel  experiments cultures  of myoblasts and  myotubes were 
stained with Golgi or ER markers. A  monoclonal antibody 
against BiP (Bole et al.,  1986) was used for the ER, and both 
wheat germ agglutinin and a Golgi-specific monoclonal anti- 
body (Allan and Kreis, 1986) for the Golgi apparatus. Simi- 
lar results were obtained with both Golgi markers. 
In  both  myoblasts and  myotubes  stained  with  anti-BiP 
(Fig.  6,  A  and  B),  the  ER  forms  an  extensive  network 
throughout the cell. Details of the network can be observed 
toward the edge of the myoblasts, where the cell is thinner. 
The pattern of anti-BiP staining is similar to that observed 
with lipid dye markers (Terasaki et al.,  1984),  but differs 
somewhat from that observed with antibodies to membrane 
fractions derived from the rough ER (Louvard et al.,  1982). 
The most conspicuous difference is the bright perinuciear 
staining  seen in  the  latter case.  The difference in  staining 
could occur because BiP is a luminal protein, rather than a 
membrane protein. 
As observed by others,  the Golgi pattern was strikingly 
different  in  myoblasts and  myotubes  (Tassin et al.,  1985) 
(Fig. 6, C and D). In myoblasts the Golgi apparatus was close 
to the nucleus and highly polar. A pattern of coarse dots was 
observed instead of the finely granular texture seen for the 
ER. In myotubes, evenly distributed but discontinuous Golgi 
staining was seen around each nucleus, and isolated dots of 
staining that seemed to link the Golgi apparatus from neigh- 
boring nuclei were distributed throughout the cytoplasm. 
In wild-type myotubes the pattern of internal AChR stain- 
ing  showed characteristics of both ER and Golgi (Fig.  7). 
The most prominent feature was the continuous perinuclear 
staining, which along with the diffuse staining throughout the 
cytoplasm, resembled that seen with ER markers. Coarsely 
dotted  staining,  like  that  of the  Golgi apparatus  was  also 
seen, however. In double-label experiments, such dots were 
seen to be stained not only by rho-c~-BuTx,  but also by the 
anti-Golgi antibody (Fig.  8). 
Figure 5. N-linked glycosylation of the t' subunit of surface AChR 
in wild-type and T- cells. Wild-type (Wt) or T- myotube cultures 
were incubated with a-BuTx to label the surface receptor. The cells 
were then iysed and surface AChR isolated by immunoprecipitation 
with anti-c~-BuTx antibodies as described  in Materials and Meth- 
ods. Immunoprecipitates  were either mock-digested (lanes 1), di- 
gested with endo H (lanes 2), or endo F (lanes 3), and separated 
on SDS gel and processed for Western blot analysis, using anti-7 
485 antibodies as the probe. The figure shows an autoradiogram of 
the blot.  Arrow indicates the position of the t' subunit on the gel. 
Gu et al. AChR Retention in ER of Muscle Cell Variant  733 Figure 6.  Immunofluorescent staining of C2 cells with Golgi and ER markers.  Wild-type C2 myoblasts (A and C) or myotubes (B and 
D) grown on glass  coverslips  were  fixed and permeabilized as described in Materials  and Methods.  They were then stained  with  an 
anti-Golgi (A and B) or with an anti-BiP (C and D) monoclonal antibody, followed by fluorescein- (FITC) conjugated anti-mouse antibod- 
ies. A similar staining pattern was obtained when T- cells were used.  Bar, 20 p.m. 
Figure 7. Immunocytoche~nical localization of intracellular AChRs in wild-type and T- cells. Wild-type (A and B) and T- (C and D) C2 
cells were grown on glass coverslips and switched to fusion medium. After 3 d in fusion medium, cell surface AChRs were blocked with 
unlabeled  t~-BuTx.  The cells were then fixed, permeabilized, and stained with rho-t~-BuTx  as described in Materials and Methods. Although 
C2 myoblasts in growth medium do not show any staining after this procedure  (not shown), C2 cultures in fusion medium include mono- 
nucleated cells that do express AChR. The figure shows mononucleated cells (A and C) and multinucleated myotubes (B and D). Bar, 20 #m. 
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tion of  AChR  and Golgi apparatus 
or ER in C2 myotubes.  Wild-type 
(A and B) or T- (C and D) cells 
kept for 3 d  in fusion medium 
were stained with rho-~-BuTx (B 
and D) as described in the legend 
to  Fig.  7  and,  simultaneously, 
with an anti-Golgi  (A) or anti- 
BiP  (C)  monoclonal antibody, 
followed by  fluorescein-labeled 
second antibodies. Bar, 20/zm. 
In  T-  myotubes,  the  pattern  of staining  more  closely 
resembled that of the ER. A bright, continuous perinuclear 
staining was seen, along with a diffuse, finely textured stain- 
ing in the cytoplasm. No evidence was found for the coarse, 
dot-like pattern of the Golgi staining (Fig. 7). 
The distinction in rho-a-BuTx staining pattern  in wild- 
type and T- cells was most clearly demonstrated in myo- 
blasts.  Although C2  myoblasts make little,  if any, AChR 
when cultured under growth conditions, occasional mononu- 
cleated cells in fusion medium showed intense intracellular 
staining with rho-o~-BuTx. In wild-type cultures, this stain- 
ing was near the nucleus and was distinctly polar, resembling 
that seen with Golgi markers;  in T- cultures, in contrast, 
the staining was evenly distributed throughout the cytoplasm 
(Fig. 7). 
Localization of the Internal AChR by Subcellular 
Fractionation 
As an additional method of localizing the internal pool of 
AChR in wild-type and T- cells, we used a sucrose gradient 
centrifugation procedure recently developed by Smith et al. 
(1987) that separates membranes derived from the Golgi ap- 
paratus and those from the ER. When applied to C2 myo- 
tubes cultures, these methods gave good separation between 
the Golgi marker enzyme, mannosidase II (Novikoff et al., 
1983), and a marker for the endoplasmic reticulum, glucose- 
6-phosphatase (Farquhar et al., 1974) (Fig. 6, B and D); an- 
other  Golgi  marker,  UDP-galactose/N-acetylglucosamine 
galactosyltransferase, which  is  located  in  the  trans-Golgi 
(Roth and Berger, 1982; Slot and Geuze, 1983),  sedimented 
to a density that was slightly higher than that of mannosidase 
II, in agreement with the results of Smith et al. (1987).  Al- 
though the gradients showed little or no contamination of 
Golgi fractions by the ER marker enzymes, there was a small 
peak of activity of both Golgi markers in the fractions con- 
taining ER markers. Surface membrane, identified by bound 
~25I-ot-BuTx, was also found at approximately the same posi- 
tion in the gradient as glucose-6-phosphatase, the ER marker 
(data not shown). Thus the fractions containing ER are heter- 
ogeneous. 
To examine the internal AChR, myotube cultures were in- 
cubated with unlabeled c~-BuTx to block surface receptors, 
then homogenized, and subjected to sucrose gradient cen- 
trifugation. Gradient fractions were analyzed for AChR by 
~25I-u-BuTx binding, and for ER and Golgi markers as de- 
scribed  in  Materials and  Methods.  In homogenates from 
wild-type myotube cultures, the major peak of AChR was 
found in a position coincident with the ER marker, glucose- 
6-phosphatase (Fig. 9, a and b). A smaller peak was also de- 
tected in the fractions containing the Golgi markers. Analy- 
sis of T- homogenates, however,  showed that virtually all of 
the AChR was in the region of the gradient containing ER 
membranes (Fig. 9, c and d). Little, if any, AChR was de- 
tected in the Golgi region. These experiments demonstrate 
clearly that the internal AChR in T- myotubes is not accu- 
mulated in the Golgi apparatus, and suggest that it may be 
retained in the ER. 
Discussion 
We have compared the properties and intracellular location 
of AChRs in wild-type C2  muscle cells and in T-,  a  C2 
variant that accumulates AChR in an intracellular pool. The 
principal conclusion of our experiments is that in wild-type 
cells AChR is present both in the Golgi apparatus and in the 
ER;  T- cells, in contrast, have reduced levels of AChR in 
the Golgi apparatus, and accumulate it in the ER. As shown 
elsewhere, inefficient transport from the ER to the Golgi ap- 
paratus is not a general defect in T- cells, but appears to be 
specific for the AChR. Thus T- myotubes have on their sur- 
face normal amounts of both the insulin receptor and the 
transferrin receptor and, after infection with influenza virus 
show normal transport of hemagglutinin protein to the sur- 
face (Gu et al.,  1989;  see also Fig. 4  legend). 
In normal myotubes •30%  of the total AChR is intracellu- 
lar, most of which serves as precursor for receptor on the 
surface (Devreotes et al., 1977; Gu et al., 1989). Fambrough 
and  Devreotes  (1978) localized intracellular AChR to the 
Golgi, using ultrastructural methods. Recent pulse-labeling 
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Figure 9.  Subceilular localization of AChR 
in  wild-type and  T- myotubes. Myotube 
cultures of wild-type (A and B) or T- (C 
and D) cells were incubated with excess un- 
labeled ot-BuTx  to block surface AChR. The 
cells  were then homogenized and  centri- 
fuged on 20-69%  sucrose gradients as de- 
scribed in Materials and Methods. 20 200-#1 
fractions were collected from each gradient 
and assayed, for toxin-binding activity and 
for markers of the endoplasmic reticulum 
and the Golgi apparatus. The data were nor- 
malized to the highest activity for each mark- 
er. a  and c,  toxin-binding activity ([]); b 
and  d,  glucose-6-phosphate activity  (o), 
mannosidase II activity (e) and UDP-galac- 
tose/N-acetylglucosamine  galactosyitrans- 
ferase activity (,,). 
experiments,  followed  by  subcellular  fractionation,  have 
shown that assembled AChR is also present in the ER (Smith 
et al., 1987). Our results on wild-type C2 cells confirm both 
of these findings. Subcellular fractionation shows that most 
of the intracellular AChR is in fractions that contain mem- 
branes from the ER, but that a small peak of AChR is also 
in fractions containing Golgi membranes (Fig. 9). Immuno- 
cytochemical experiments also show distinct staining for the 
AChR in the Golgi apparatus, as well as a more diffuse stain- 
ing that is characteristic of the ER. Although more promi- 
nent in the Golgi than in the ER when viewed by immunocy- 
tochemistry, most of the intracellular AChR in C2 myotubes 
is probably in the ER. The subcellular fractionation results 
are consistent with this distribution,  as is the finding that 
most of the internal AChR in wild-type cells contains only 
endo H-sensitive sugars  (Gu,  Y.  and  Z.  W.  Hall,  unpub- 
lished observations). 
In contrast to wild-type cells,  most of the AChR  in T- 
myotubes is intracellular and does not serve as precursor for 
surface receptor (Gu et al.,  1989)• Virtually all of the inter- 
nal AChR appears to be in the ER. No AChR was observed 
in the Golgi fractions after subcellular fractionation (Fig. 9); 
the more sensitive immunocytochemical experiments also 
failed to detect AChR in the Golgi apparatus. In neither myo- 
blasts nor myotubes was there any sign of the coarsely dotted 
staining pattern that is characteristic of the Golgi apparatus. 
Analysis of N-linked glycosylation of the AChR subunits 
in the T- variant further indicated that they were accumu- 
lated in a pre-Golgi compartment. Both ~ and c5 subunits of 
the internal AChR in the T- variant lacked endo H-resistant 
oligosaccharides. Because the processing of N-linked sugars 
from high-mannose,  endo H-sensitive forms to complex, 
endo H-resistant forms occurs in the Golgi apparatus (Korn- 
feld and Kornfeld, 1985), AChR that is retained in the ER 
would necessarily lack endo H-resistant oligosaccharides. 
Accumulation of fully assembled  AChR  in the  ER of T- 
myotubes is consistent with the earlier finding by Smith et 
al.  (1987) that the AChR is assembled there. 
Our results are most consistent with AChR localization in 
the  ER of T- myotubes,  although the possibility  that  the 
receptor accumulates in a closely related compartment can- 
not be ruled out. The pattern of AChR staining in T- cells 
strongly resembles the pattern seen with anti-BiP, but is not 
identical with it.  First, the AChR staining in T- cells was 
often more finely textured than anti-BiP staining.  Second, 
the most prominent feature of the AChR staining, the intense 
perinuclear ring, was only occasionally seen with anti-BiP. 
Perinuclear ER is observed with the electron microscope, 
however, and other ER antibodies show strong perinuclear 
staining (Louvard et al., 1982). Thus, an alternative explana- 
tion for the discrepancy is that the pattern seen with anti-BiP, 
which is a luminal protein, may not reflect the complete dis- 
tribution of ER membranes. 
What is the primary defect in T- cells? Although a num- 
ber of genetic variants of mammalian  cell lines  that lack 
glycosylation  processing  enzymes  have  been  described 
(Stanley, 1984; Kingsley et al.,  1986), the T- variant does 
not appear to be one of these• First, our experiments show 
no evidence for a general defect in glycosylation. Lectin sen- 
sitivity, and the processing of fibronectin and influenza virus 
HA protein appear to be unchanged in T- cells. Second, the 
T- phenotype cannot be reproduced in wild-type cells by 
inhibitors of enzymes in the glycosylation pathway (Gu, Y. 
and Z. W.  Hall, unpublished results). 
A transport-defective mutant of  CHO cells, gro29, has also 
been described by Tufaro et al. (1987), but the properties of 
this variant are different from those of the T- variant of C2 
cells• In gro29 cells, both oligosaccharide processing and ex- 
port of viral protein is defective and protein accumulates in 
or near the Golgi apparatus.  In T- cells, in contrast, viral 
protein is processed and transported to the surface with nor- 
mal kinetics. 
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specific to the AChR. The latter possibility raises the ques- 
tion of whether the defect is in the AChR itself or is in an- 
other protein.  This  question  is  unresolved by  our experi- 
ments. A  previous finding that the ct subunit is less rapidly 
degraded in T- than in wild-type cells (Gu, Y., manuscript 
submitted for publication) could be explained by a change in 
primary sequence of the a  subunit, but could also have other 
explanations. 
One of the most puzzling aspects of our experiments is that 
a  minor proportion of the AChRs  in T- cells  is  normally 
glycosylated (Fig.  5) and is transported to the surface with 
normal kinetics (Gu et al.,  1989). One possible explanation 
is that genes coding for the ct subunit on both chromosomes 
are expressed.  It is possible that two copies of the a  subunit 
are produced, one of which is mutated. If AChRs were as- 
sembled  randomly,  then only a  minority of AChRs would 
have two correct ot subunits. Another possibility is that one 
of the subunits undergoes a conformational change before as- 
sembly such that incorrect folding, which is normally a rare 
event, becomes more frequent after a mutational alteration. 
The incorrectly folded subunit would then be assembled to 
form a defective AChR. We have shown that internal AChRs 
bind t~-BuTx and have a normal sedimentation coefficient (Gu 
et al., 1989), but their properties are otherwise unexamined. 
Such  suggestions  imply  that transport mechanisms  can 
distinguish between authentic and defective AChRs. Numer- 
ous examples are available of defective or unassembled pro- 
teins produced by mutation or by  recombinant techniques 
that do not exit the ER (e.g., Leitersdorf et al., 1988; Doms 
et al., 1988; Gething et al., 1986; Doyle et al., 1985, 1986). 
In some cases these have been shown to be complexed to a 
78-kD protein, BiP, found in the ER lumen (Haas and Wabl, 
1983; Bole et al.,  1986; Munro and Pelham,  1986; Gething 
et al.,  1986). In preliminary experiments, we found no evi- 
dence  for  AChR-BiP  complexes  in  T-  cells.  BiP  is  not 
precipitated by antibodies to the AChR, nor do anti-BiP anti- 
bodies precipitate the a  subunit of the AChR (Gu,  Y.  and 
Z. W.  Hall,  unpublished data).  The retention of the AChR 
in the ER is thus apparently not due to its association with 
BiP. 
A  final possibility arises  from the observation that myo- 
tubes normally have a stable internal pool of AChRs that does 
not serve as precursor for surface receptor (Devreotes et al., 
1977; Gu et al., 1989). The function and location of this pool 
is unknown, but it could reflect the ability of the cell to regu- 
late the proportion of AChR that is on its surface. If so, regu- 
lation in the T- variant might be altered so that receptor is 
preferentially  retained.  An  intriguing  feature  of  such  a 
scheme would be the possibility of regulating transport from 
the ER to the Golgi apparatus to achieve different densities 
of surface AChR. 
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